What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Cytovene
97%DGNews: Oral Cytovene for Prevention of CMV Disease Cleared By FDA
96%DGNews: Oral Cytovene Can Prevent CMV Disease in Liver Transplant Recipients
95%DGNews: Valcyte Approved for the Prevention of CMV in High-Risk Kidney, Kidney-Pancreas and Heart Transplant Patients
95%DGNews: Oral Cytovene May Prevent Deadly Infection In Kidney Transplant Recipients
93%DGNews: FDA Approves Valcyte (Valganciclovir) For Cytomegalovirus Retinitis In AIDS Patients
92%DGNews: Committee Backs Valganciclovir HCl To FDA For AIDS-Related Cytomegalovirus Retinitis
92%DGNews: CROI: Oral Valganciclovir Comparable To IV Cytovene For Cytomegalovirus
90%DGNews: Once-Daily Valcyte (Valganciclovir) Prevents Cytomegalovirus After Kidney Transplant
87%DGNews: Ganciclovir Implant More Effective Than IV Therapy for CMV Retinitis
84%DGNews: Preventive Antiviral Therapy Could Save Hundreds Of Kidneys Every Year
82%DGNews: ATC: New Data Reveal Ganciclovir (Valcyte/Cymevene) Reduces The Risk Of Cancer In Kidney Transplant Patients
80%DGNews: New Invirase Resistance/Cross Resistance Data
78%DGNews: FDA Recommends Full Approval for Hivid(r) Combination Therapy
77%DGNews: Invirase Combined with Hivid Reduces Deaths by More Than Two Thirds
74%DGNews: Hope for Kidney Transplant Patients of Improved Graft Survival
74%DGNews: DG DISPATCH - CROI: Oral Valganciclovir As Effective As IV Ganciclovir For CMV Retinitis
72%DGNews: CellCept (Mycophenolate Mofetil) Reduces Long-Term Risk Of Kidney Rejection In Transplants
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.